Cargando…

High dose vitamin D supplementation does not affect biochemical bone markers in multiple sclerosis – a randomized controlled trial

BACKGROUND: People with multiple sclerosis have high risk of osteoporosis and fractures. A poor vitamin D status is a risk factor for MS, and vitamin D supplementation has been recommended both to prevent MS progression and to maintain bone health. METHODS: We assessed the effect of 20,000 IU vitami...

Descripción completa

Detalles Bibliográficos
Autores principales:	Holmøy, Trygve, Lindstrøm, Jonas Christoffer, Eriksen, Erik Fink, Steffensen, Linn Hofsøy, Kampman, Margitta T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381015/ https://www.ncbi.nlm.nih.gov/pubmed/28376767 http://dx.doi.org/10.1186/s12883-017-0851-0

Ejemplares similares

Can vitamin D(3) supplementation prevent bone loss in persons with MS? A placebo-controlled trial
por: Steffensen, Linn H., et al.
Publicado: (2011)

Timing of use of cod liver oil, a vitamin D source, and multiple sclerosis risk: The EnvIMS study
por: Cortese, Marianna, et al.
Publicado: (2015)

Natural Variation of Vitamin D and Neurofilament Light Chain in Relapsing-Remitting Multiple Sclerosis
por: Røsjø, Egil, et al.
Publicado: (2020)

Level of education and multiple sclerosis risk after adjustment for known risk factors: The EnvIMS study
por: Bjørnevik, Kjetil, et al.
Publicado: (2016)

An Update on Vitamin D and Disease Activity in Multiple Sclerosis
por: Smolders, Joost, et al.
Publicado: (2019)

Month of birth and risk of multiple sclerosis: confounding and adjustments
por: Torkildsen, Øivind, et al.
Publicado: (2014)

Reply to comment: Month of birth and risk of multiple sclerosis: confounding and adjustments
por: Torkildsen, Øivind, et al.
Publicado: (2014)

Bone Turnover and Metabolism in Patients with Early Multiple Sclerosis and Prevalent Bone Mass Deficit: A Population-Based Case-Control Study
por: Moen, Stine Marit, et al.
Publicado: (2012)

Bone mineral density in patients with multiple sclerosis, hereditary ataxia or hereditary spastic paraplegia after at least 10 years of disease - a case control study
por: Simonsen, Cecilia Smith, et al.
Publicado: (2016)

The Effect of Vitamin A Supplementation on Biochemical Parameters in Multiple Sclerosis Patients
por: Jafarirad, Sima, et al.
Publicado: (2013)

Extensive Multiple Sclerosis Reactivation after Switching from Fingolimod to Rituximab
por: Holmøy, Trygve, et al.
Publicado: (2018)

High‐throughput sequencing of immune repertoires in multiple sclerosis
por: Lossius, Andreas, et al.
Publicado: (2016)

Diffuse alveolar hemorrhage during alemtuzumab infusion in a patient with multiple sclerosis: a case report
por: Myro, Aija Zuleron, et al.
Publicado: (2018)

Adverse events with fatal outcome associated with alemtuzumab treatment in multiple sclerosis
por: Holmøy, Trygve, et al.
Publicado: (2019)

Effects of vitamin K supplementation on reproductive performance and bone metabolism-related biochemical markers in lactation sows
por: Wang, Huakai, et al.
Publicado: (2023)

Epstein-Barr Virus in Systemic Lupus Erythematosus, Rheumatoid Arthritis and Multiple Sclerosis—Association and Causation
por: Lossius, Andreas, et al.
Publicado: (2012)

Training physicians in providing complex information to patients with multiple sclerosis: a randomised controlled trial
por: Nordfalk, Jenny M, et al.
Publicado: (2022)

Antiepileptic and Antidepressive Polypharmacy in Patients with Multiple Sclerosis
por: Beiske, Georg Anton Giæver, et al.
Publicado: (2015)

Impact of Vitamin D Supplementation on Multiple Sclerosis
por: Gandhi, Fenil, et al.
Publicado: (2021)

G1m1 predominance of intrathecal virus‐specific antibodies in multiple sclerosis
por: Tomescu‐Baciu, Alina, et al.
Publicado: (2018)

The effect of vitamin D supplementation on serum total 25(OH) levels and biochemical markers of skeletal muscles in runners
por: Żebrowska, Aleksandra, et al.
Publicado: (2020)

Tuberculin responses after BCG vaccination predict amyotrophic lateral sclerosis risk
por: Nakken, Ola, et al.
Publicado: (2023)

A One Year Follow-Up Study of Natural Killer and Dendritic Cells Activities in Multiple Sclerosis Patients Receiving Glatiramer Acetate (GA)
por: Høglund, Rune A., et al.
Publicado: (2013)

High-dose vitamin D supplementation in multiple sclerosis – results from the randomized EVIDIMS (efficacy of vitamin D supplementation in multiple sclerosis) trial
por: Dörr, Jan, et al.
Publicado: (2020)

Vitamin D(3) supplementation does not enhance the effects of resistance training in older adults
por: Mølmen, Knut Sindre, et al.
Publicado: (2021)

Biochemical markers after the Norseman Extreme Triathlon
por: Nyborg, Christoffer, et al.
Publicado: (2020)

Inflammation Markers in Multiple Sclerosis: CXCL16 Reflects and May Also Predict Disease Activity
por: Holmøy, Trygve, et al.
Publicado: (2013)

Severe inflammatory disease activity 14 months after cessation of Natalizumab in a patient with Leber’s optic neuropathy and multiple sclerosis – a case report
por: Holmøy, Trygve, et al.
Publicado: (2016)

Strong tuberculin response after BCG vaccination is associated with low multiple sclerosis risk: a population-based cohort study
por: Nakken, Ola, et al.
Publicado: (2022)

Vitamin A supplementation and risk of atopy: long-term follow-up of a randomized trial of vitamin A supplementation at six and nine months of age
por: Kiraly, Nicholas, et al.
Publicado: (2013)

Vitamin D Supplementation Practices among Multiple Sclerosis Patients and Professionals
por: Galus, Weronika, et al.
Publicado: (2022)

Assessment of Biochemical and Densitometric Markers of Calcium-Phosphate Metabolism in the Groups of Patients with Multiple Sclerosis Selected due to the Serum Level of Vitamin D(3)
por: Niedziela, Natalia, et al.
Publicado: (2018)

Vitamin D supplementation does not prevent the recurrence of Graves’ disease
por: Cho, Yoon Young, et al.
Publicado: (2020)

Selective intrathecal enrichment of G1m1‐positive B cells in multiple sclerosis
por: Lossius, Andreas, et al.
Publicado: (2017)

Vitamin D supplementation does not improve CVD risk factors in vitamin D-insufficient subjects
por: Kubiak, Julia, et al.
Publicado: (2018)

In Silico Prediction Analysis of Idiotope-Driven T–B Cell Collaboration in Multiple Sclerosis
por: Høglund, Rune A., et al.
Publicado: (2017)

Abuse and revictimization in adulthood in multiple sclerosis: a cross-sectional study during pregnancy
por: Eid, Karine, et al.
Publicado: (2022)

Effectiveness of Vitamin D Supplementation in the Management of Multiple Sclerosis: A Systematic Review
por: Berezowska, Monika, et al.
Publicado: (2019)

Vitamin D supplementation differentially affects seasonal multiple sclerosis disease activity
por: Miclea, Andrei, et al.
Publicado: (2017)

Vitamin D Supplementation in Multiple Sclerosis: A Critical Analysis of Potentials and Threats
por: Feige, Julia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1l48170jnfp09b96favc52rnc8